Abstract
Glutathione (GSH) is the most abundant antioxidant found in living organisms and has multiple functions, most of which maintain cellular redox homeostasis. GSH preserves sufficient levels of cysteine and detoxifies xenobiotics while also conferring therapeutic resistance to cancer cells. However, GSH metabolism plays both beneficial and pathogenic roles in a variety of malignancies. It is crucial to the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. Excess GSH promotes tumor progression, where elevated levels correlate with increased metastasis. In this review, we discuss recent studies that focus on deciphering the role of GSH in tumor initiation and progression as well as mechanisms underlying how GSH imparts treatment resistance to growing cancers. Targeting GSH synthesis/utilization therefore represents a potential means of rendering tumor cells more susceptible to different treatment options such as chemotherapy and radiotherapy.
Keywords
GlutathioneCancer researchCancer cellBiologyCancerDetoxification (alternative medicine)Tumor progressionMetabolismBiochemistryMedicineEnzymePathologyGenetics
Affiliated Institutions
Related Publications
Oxidative Stress in Cancer
Contingent upon concentration, reactive oxygen species (ROS) influence cancer evolution in apparently contradictory ways, either initiating/stimulating tumorigenesis and support...
Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion
The effects of L-buthionine-(S,R)-sulfoximine (BSO) on the proliferation of normal rat kidney fibroblasts (NRK-49F) were determined and compared with the effects of BSO on cellu...
Regulation of Ascorbate-Glutathione Pathway in Mitigating Oxidative Damage in Plants under Abiotic Stress
Reactive oxygen species (ROS) generation is a usual phenomenon in a plant both under a normal and stressed condition. However, under unfavorable or adverse conditions, ROS produ...
Self-Assembled Copper–Amino Acid Nanoparticles for in Situ Glutathione “AND” H<sub>2</sub>O<sub>2</sub> Sequentially Triggered Chemodynamic Therapy
Nanoformulations that can respond to the specific tumor microenvironment (TME), such as a weakly acidic pH, low oxygen, and high glutathione (GSH), show promise for killing canc...
Simultaneous Fenton‐like Ion Delivery and Glutathione Depletion by MnO<sub>2</sub>‐Based Nanoagent to Enhance Chemodynamic Therapy
Abstract Chemodynamic therapy (CDT) utilizes iron‐initiated Fenton chemistry to destroy tumor cells by converting endogenous H 2 O 2 into the highly toxic hydroxyl radical ( . O...
Publication Info
- Year
- 2018
- Type
- review
- Volume
- 217
- Issue
- 7
- Pages
- 2291-2298
- Citations
- 1173
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1173
OpenAlex
Cite This
Ankita Bansal,
M. Celeste Simon
(2018).
Glutathione metabolism in cancer progression and treatment resistance.
The Journal of Cell Biology
, 217
(7)
, 2291-2298.
https://doi.org/10.1083/jcb.201804161
Identifiers
- DOI
- 10.1083/jcb.201804161